Clinical Research Facility

Chelsea, Michigan 48118

We've found

2 trials

at this facility

A Preliminary Study of the Efficacy and Safety of MK-8521 for Type 2 Diabetes (MK-8521-004)

Status: Enrolling, Phase II
Updated: 12/29/2016

from

Chelsea, MI

Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Chelsea, MI

Use our guide to learn which trials are right for you!